Taken together, our observations suggest that LicA should be regarded as a promising anti-cancer agent against cervical cancer cells, and that the inhibition of PI3K/Akt/mTOR-mediated autophagy may enhance the anti-tumor effects of LicA, such that this inhibition may have therapeutic implications in the treatment of cervical cancer. The gene discussed is MTOR; the disease is cervical cancer.